Quinacrine: Uses, Benefits, and Safety Information

Introduction

Quinacrine is a synthetic analog of quinine with a long history of use as an antimalarial drug. It has also been used to treat various other conditions, including giardiasis, lupus erythematosus, and certain types of cancer. This article provides a comprehensive overview of quinacrine, including its uses, benefits, safety information, and more.

Chemical Composition and Properties

Quinacrine has the molecular formula C23H30ClN3O and a molecular weight of 399.95 g/mol. It is an acridine derivative with a tricyclic ring structure similar to other antimalarial drugs like chloroquine. Quinacrine is a yellow crystalline powder that is slightly soluble in water and soluble in alcohol and chloroform.

Mechanism of Action

Quinacrine‘s antimalarial activity is believed to be due to its ability to intercalate into DNA and interfere with DNA replication and transcription in the malaria parasite (Ehsanian et al., 2011). It also has antiprotozoal effects against organisms like Giardia lamblia and may have anti-inflammatory and immunomodulatory properties.

Medical Uses

Quinacrine has been used to treat various conditions, including:

• Malaria: Quinacrine was widely used as an antimalarial drug during World War II and remains an option for treatment-resistant cases (Wallace, 2015).
• Giardiasis: Quinacrine is effective against the intestinal parasite Giardia lamblia and may be used as a second-line treatment for giardiasis (Arguin & Tan, 2019).
• Lupus erythematosus: Quinacrine has been used as an adjunctive treatment for cutaneous lupus erythematosus, particularly in patients with antimalarial-induced photosensitivity (Chasset et al., 2019).
• Cancer: Quinacrine has shown anticancer activity in preclinical studies and has been investigated as a potential treatment for various types of cancer, including brain tumors and prostate cancer.

Dosage and Administration

The recommended dosage of quinacrine varies depending on the condition being treated. For malaria prophylaxis, the typical adult dose is 100 mg daily. For treatment of giardiasis, the dose is usually 100 mg three times daily for 5-7 days. Quinacrine is available as 100 mg tablets for oral administration.

Specific Dosing Considerations

Fair-skinned individuals may require lower doses of quinacrine due to an increased risk of photosensitivity reactions. The drug should be used with caution in patients with liver or kidney dysfunction, and dose adjustments may be necessary.

Interactions

Quinacrine may interact with other medications, including:

• Antacids and adsorbents: These agents may decrease the absorption of quinacrine.
• Anticoagulants: Quinacrine may enhance the effects of warfarin and other anticoagulants, increasing the risk of bleeding.
• Antimalarials: Concurrent use of quinacrine with other antimalarial drugs may increase the risk of adverse effects.

Safety and Side Effects

Common side effects of quinacrine include gastrointestinal disturbances (nausea, vomiting, diarrhea), headache, and skin reactions (rash, pruritus). More serious adverse effects may include liver toxicity, neurological effects (seizures, psychosis), and vision changes. Quinacrine may also cause yellow discoloration of the skin, sclerae, and bodily fluids.

Safety Precautions in Compounding

Quinacrine should be handled with caution during compounding due to its potential for skin and eye irritation. Proper personal protective equipment, including gloves and eye protection, should be worn when handling the drug.

Historical Context

Quinacrine was first synthesized in the early 1930s and was widely used as an antimalarial drug during World War II. It largely replaced quinine as the primary antimalarial agent due to its greater availability and efficacy. However, the development of chloroquine and other antimalarial drugs in the 1940s and 1950s led to a decline in quinacrine use.

Trade Names and Synonyms

Quinacrine is known by various trade names and synonyms, including:

• Atabrine (U.S.)
• Atebrin (Germany)
• Mepacrine
• Acriquine
• Erion

Research and Future Directions

Recent research has explored the potential of quinacrine for various applications, including:

• Anticancer activity: Preclinical studies have shown that quinacrine may have activity against various types of cancer, including glioblastoma, colorectal cancer, and prostate cancer.
• Antiprion properties: Quinacrine has been investigated as a potential treatment for prion diseases like Creutzfeldt-Jakob disease due to its ability to inhibit prion protein aggregation.
• Antiviral effects: Some studies have suggested that quinacrine may have antiviral activity against viruses like Zika virus and Ebola virus.

Regulatory and Legal Status

Quinacrine is not currently approved by the U.S. Food and Drug Administration (FDA) for any indication. It was previously marketed in the United States under the trade name Atabrine but was discontinued in the 1970s. Quinacrine remains available in some countries for the treatment of malaria and other conditions.

Legal Restrictions

In the United States, quinacrine is not FDA-approved for intrauterine administration as a means of non-surgical female sterilization. The use of quinacrine for this purpose is considered an off-label use and is not legally permitted.

Alternatives and Replacements

Several drugs have been investigated as potential replacements for quinacrine, particularly in the treatment of malaria. These include:

• Chloroquine: A 4-aminoquinoline derivative that largely replaced quinacrine as the primary antimalarial drug in the mid-20th century.
• Primaquine: An 8-aminoquinoline derivative used for the radical cure of Plasmodium vivax malaria.
• Mefloquine: A synthetic analog of quinine used for malaria prophylaxis and treatment.

Compounding Information

Quinacrine may be compounded for specific uses, such as in the treatment of lupus erythematosus or other inflammatory conditions. However, compounding pharmacies must follow appropriate safety guidelines and regulations when preparing quinacrine formulations.

Safety Information for Specific Uses

Quinacrine should not be compounded for intrauterine administration as a means of non-surgical female sterilization due to safety concerns and legal restrictions. The drug may cause serious adverse effects when used in this manner, including pelvic inflammation, scarring, and perforation of the uterus.

Clinical Trials and Studies

Several clinical trials have investigated the use of quinacrine for various conditions. A randomized, double-blind, placebo-controlled trial published in the New England Journal of Medicine in 1993 found that quinacrine was effective in the treatment of giardiasis, with a cure rate of 95% compared to 53% for placebo (Wolfe, 1993).

Biological Activities and Classification

Quinacrine is classified as an acridine derivative and has a wide range of biological activities, including antimalarial, antiprotozoal, antibacterial, and anti-inflammatory effects. Its primary mechanism of action is thought to be interference with DNA replication and transcription through intercalation into DNA.